Arteriogenic therapy by intramyocardial sustained delivery of a novel growth factor combination prevents chronic heart failure. [electronic resource]
Producer: 20111027Description: 1059-69 p. digitalISSN:- 1524-4539
- Angiogenesis Inducing Agents -- administration & dosage
- Animals
- Capsules
- Cardiomegaly -- drug therapy
- Cell Movement -- drug effects
- Cell Proliferation -- drug effects
- Chronic Disease
- Coronary Vessels -- drug effects
- Drug Therapy, Combination
- Fibroblast Growth Factor 2 -- administration & dosage
- Heart Failure -- prevention & control
- Hepatocyte Growth Factor -- administration & dosage
- Male
- Mice
- Mice, Inbred BALB C
- Mitogen-Activated Protein Kinases -- metabolism
- Myocardium
- Neovascularization, Physiologic -- drug effects
- Oncogene Protein v-akt -- metabolism
- Rats
- Rats, Wistar
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.